MedPath

Surveys for assessment of urogenital schistosomiasis in pre-school, school-aged children, adolescents and adults in Zanzibar (Unguja and Pemba Islands)

Not Applicable
Completed
Conditions
Schistosoma haematobium infections (urogenital schistosomiasis)
Infections and Infestations
Schistosoma haematobium, urogenital schistosomiasis, bilharziasis
Registration Number
ISRCTN17656730
Lead Sponsor
Swiss Tropical and Public Health Institute
Brief Summary

2021 Interim results article in https://pubmed.ncbi.nlm.nih.gov/33577601/ (added 31/08/2021)

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
26970
Inclusion Criteria

1. Children attending the selected nurseries and schools
2. Adolescents or adults aged =13 years from the selected shehias, including pregnant women, only one adolescent and/or adult per household eligible
3. Submitted informed consent form (ICF) signed by a parent or legal guardian in case of participating children and adolescents, or signed by the participant in case of participating adults
4. Able to provide one urine sample with sufficient volume to perform diagnostic tests

Exclusion Criteria

Does not meet inclusion criteria

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Current primary outcome measure as of 27/07/2020:<br>Number of S. haematobium infected individuals detected by the urine filtration method (detecting S. haematobium eggs in 10 ml urine) and reagent strip method (Hemastix; detecting microhaematuria in urine) applied on a single urine sample per participant in each annual cross-sectional survey in 2018, 2019, 2020, and 2021<br><br>Previous primary outcome measure:<br>Number of S. haematobium infected individuals detected by the urine filtration method (detecting S. haematobium eggs in 10 ml urine) and reagent strip method (Hemastix; detecting microhaematuria in urine) applied on a single urine sample per participant in each cross-sectional survey at 0, 1, 2, and 3 years
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath